Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.11
Delayed Data
As of Jul 31
 -0.10 / -1.09%
Today’s Change
4.74
Today|||52-Week Range
11.71
+4.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line28.5M9.6M11.0M25.2M
 
 
 
 
 
Depreciation2.9M3.4M860.0K852.0K
 
 
 
 
 
Total Other Cash Flow-609.0K31.0M4.6M5.1M
 
 
 
 
 
Funds From Operations29.6M37.3M16.7M30.8M
 
 
 
 
 
Funds From/For Other Operating Expenses101.0K-6.3M7.2M3.2M
 
 
 
 
 
Net Cash Flow - Operating Activities29.5M43.5M9.5M27.6M
 
 
 
 
 
 
InvestingIncrease In Investments-2.3M-75.0K0.000.00
 
 
 
Decrease In Investments4.7M0.00379.0K0.00
 
 
 
Capital Expenditures0.00-1.1M-324.0K-1.5M
 
 
 
 
Net Assets From Acquisitions -21.3M0.000.000.00
 
 
Other Investing - Uses0.000.000.00-4.8M
 
 
Net Cash Flow Investing-18.8M-1.2M55.0K-6.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-1.1M161.0K-1.6M
 
 
 
 
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale6.3M3.5M1.7M5.2M
 
 
 
 
 
Common Preferred Redeemed-3.5M-24.8M-12.5M-24.4M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.002.3M0.00
 
 
Other Uses - Financing0.002.3M0.000.00
 
 
Net Cash Flow - Financing2.8M-24.7M-8.4M-20.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash195.0K-45.0K371.0K-175.0K
 
 
 
 
 
 
Net Change In Cash13.4M17.6M1.2M600.0K